Human norovirus inhibition by a human milk oligosaccharide

Virology
Anna KoromyslovaGrant Hansman

Abstract

Human noroviruses are the leading cause of outbreaks of acute gastroenteritis. Norovirus interactions with histo-blood group antigens (HBGAs) are known to be important for an infection. In this study, we identified the HBGA binding pocket for an emerging GII genotype 17 (GII.17) variant using X-ray crystallography. The GII.17 variant bound the HBGA with an equivalent set of residues as the leading pandemic GII.4 variants. These structural data highlights the conserved nature of HBGA binding site between prevalent GII noroviruses. Noroviruses also interact with human milk oligosaccharides (HMOs), which mimic HBGAs and may function as receptor decoys. We previously showed that HMOs inhibited the binding of rarely detected GII.10 norovirus to HBGAs. We now found that an HMO, 2'-fucosyllactose (2'FL), additionally blocked both the GI.1 and GII.17 noroviruses from binding to HBGAs. Together, these findings provide evidence that 2'FL might function as a broadly reactive antiviral against multiple norovirus genogroups.

Citations

Jan 18, 2018·Molecular Nutrition & Food Research·Vasily MorozovClemens Kunz
Aug 4, 2018·Journal of Pediatric Gastroenterology and Nutrition·Manuela DonalisioDavid Lembo
Oct 26, 2018·Journal of Virology·Turgay KilicGrant S Hansman
Nov 16, 2018·Chemistry : a European Journal·Katharina S BücherLaura Hartmann
Dec 14, 2018·Journal of Virology·Anna D KoromyslovaGrant S Hansman
Jan 4, 2019·Journal of Virology·Kerstin RuoffGrant Hansman
Oct 24, 2019·Chembiochem : a European Journal of Chemical Biology·Robert CreutznacherAlvaro Mallagaray
Apr 24, 2020·Journal of Virology·Anna D KoromyslovaGrant S Hansman
Sep 12, 2020·Critical Reviews in Food Science and Nutrition·Emmanuel Pérez-EscalanteLuis Guillermo González-Olivares
May 13, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Vasily MorozovFranz-Georg Hanisch
Jul 18, 2018·Frontiers in Pediatrics·Vassilis TriantisR J Joost van Neerven
Aug 17, 2019·Frontiers in Immunology·Ignasi Azagra-BoronatFrancisco J Pérez-Cano
Oct 4, 2017·The Journal of Infectious Diseases·Lisa C LindesmithRalph S Baric
Mar 31, 2018·Frontiers in Immunology·Kirsty Le DoarePia S Pannaraj
Mar 23, 2019·Nature Communications·Alvaro MallagarayThomas Peters
May 28, 2020·Frontiers in Immunology·Marit ZuurveldLinette E M Willemsen
Feb 24, 2019·The Journal of Antibiotics·Kelly M Craft, Steven D Townsend
Dec 26, 2018·Medicinal Research Reviews·Natalie E NetzlerPeter A White
Aug 31, 2019·Current Opinion in Chemical Biology·Joscha MeiersAlexander Titz
Dec 31, 2020·International Journal of Molecular Sciences·Oluwakemi EbenezerMichael Shapi
Mar 2, 2021·Frontiers in Immunology·Laura E CarrLaxmi Yeruva
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jasmin DülferCharlotte Uetrecht
Nov 16, 2017·ACS Infectious Diseases·Kelly M Craft, Steven D Townsend
Aug 29, 2021·Viruses·Louisa F Ludwig-BegallEtienne Thiry
Dec 8, 2021·Critical Reviews in Food Science and Nutrition·Elif SakaryaNevin Sanlier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.